Analysts think IOBT stock price could increase by 281%
Nov 14, 2025, 12:26 PM
0.52%
What does IOBT do
IO Biotech develops immune-modulating cancer therapies using its Twin technology platform, targeting tumor-induced immunosuppression. Its lead candidate, IO102-IO103, addresses key proteins IDO and PD-L1.
5 analysts think IOBT stock price will increase by 280.88%. The current median analyst target is $3.06 compared to a current stock price of $0.80. The lowest analysts target is $0.39 and the highest analyst target is $4.20.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.